PTSD Treatment and Sleep
common.study.values.description
“Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder”
The purpose of this study is to examine effects of blocking the orexin system with suvorexant after exposure-based intervention for posttraumatic stress disorder (PTSD) on sleep, PTSD symptoms, and intersession habituation.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - suvorexant
First in class orexin antagonist approved by the FDA for the treatment of insomnia
placebo
Pill with inactive ingredients
participant.views.study.view.additional
participant.views.study.view.scientific-title
Can Blocking the Orexin System Enhance Sleep's Benefits to Therapeutic Exposure for PTSD?
common.study.values.clinical-trial-id
NCT02849548
participant.views.study.view.id
zbq57b
